Bj rn Dahl f

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)

Peter Sever, Bj rn Dahl f, Neil R Poulter et al. · Drugs · 2004 · 521 citations

Thrombosis, Hypertension, Health Policy +14

Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy

Hans Ibsen, Kristian Wachtell, Michael Hecht Olsen et al. · Journal of Hypertension · 2004 · 136 citations

Lisinopril and nifedipine in essential hypertension

Ingrid Os, B Bratland, Bj rn Dahl f et al. · Journal of Hypertension · 1991 · 36 citations

Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial???lipid-lowering arm (ASCOT-LLA)

Peter Lindgren, Martin Buxton, Thomas Kahan et al. · European Journal of Cardiovascular Prevention & Rehabilitation · 2005 · 13 citations

Thrombosis, Preventive Medicine, Lipid-lowering Arm +15